Search
Search Results
##search.searchResults.foundPlural##
-
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2092PDF: 1642HTML: 806 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2181PDF: 893HTML: 365 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3579PDF: 1437HTML: 2725 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1417PDF: 822HTML: 369 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1038PDF: 591HTML: 2227Cover Letter: 219 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1463PDF: 730HTML: 1389cover letter: 234 -
SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation patients hospitalized at Neuroscience Hospital in Italy SARS CoV 2 in severe neurological patients
1186PDF: 753HTML: 270 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1274PDF: 891HTML: 118 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2705PDF: 1682HTML: 2453Table1: 214 -
WHAT ARE FUNGAL INFECTIONS?
4362PDF: 2486HTML: 27704de Pauw: 267 -
Correlation to FVIII:C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP
2324PDF: 826HTML: 903Figure 2: 239Figure 1: 196 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1675PDF: 817HTML: 1336 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1367PDF: 622HTML: 4164 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
1029PDF: 611Html: 311Suppl. Files: 197 -
-
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4065PDF: 1102HTML: 3901Untitled: 193Cneo. Fig.1: 130Untitled: 124Untitled: 149Untitled: 159 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8263PDF: 4463HTML: 7573 -
-
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3740PDF: 2614HTML: 1643 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3426PDF: 999HTML: 2995 -
CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY
4508PDF: 1807HTML: 1487Figure 1: Age distribution of Pediatric cases: 246 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1790PDF: 775HTML: 245







